The LOI pertains to the proposed establishment of a pharmaceutical manufacturing facility at Nava Raipur Pharma Park, Chhattisgarh. The proposed project involves an investment of approximately ₹200 Crore and will focus on pharmaceutical manufacturing and related healthcare manufacturing activities.
The project is expected to generate approximately 250 direct and indirect employment opportunities. According to the company, the project will expand manufacturing capacity, strengthen operational capabilities, and support long-term business growth, potentially boosting revenue multifold over time.
The investment is subject to execution of definitive agreements, receipt of applicable approvals, sanctions, incentives, and compliance with required regulations. Government incentives are subject to applicable State Government policies, approvals, and sanction orders, with roughly 60% expected on date [likely referring to initial commitment or approval stage].
The company notes that the project implementation is contingent upon various factors including regulatory approvals and market conditions, and forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from expectations.